BNKL - Bionik Laboratories Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
3/30/2016
Total Revenue
3,270
3,246
987
572
-
Cost of Revenue
1,412
1,630
403
389
-
Gross Profit
1,857
1,616
585
183
-
Operating Expenses
Research Development
3,522
3,175
2,825
2,663
1,398
Selling General and Administrative
7,801
7,580
7,116
5,536
5,172
Total Operating Expenses
11,686
11,103
10,354
8,829
6,633
Operating Income or Loss
-9,828
-9,487
-9,769
-8,646
-6,633
Interest Expense
1,163
3,267
1,937
44
3
Total Other Income/Expenses Net
-326
2,198
-1,622
4,753
7,672
Income Before Tax
-11,316
-10,557
-14,626
-3,937
1,036
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-11,316
-10,557
-14,626
-3,937
1,036
Net Income
-11,316
-10,557
-14,626
-3,937
1,036
Net Income available to common shareholders
-11,316
-10,557
-14,626
-3,937
1,036
Reported EPS
Basic
-
-4.47
-21.00
-6.00
1.50
Diluted
-
-4.47
-21.00
-6.00
-12.00
Weighted average shares outstanding
Basic
-
2,363
673
612
477
Diluted
-
2,363
673
612
533
EBITDA
-
-6,941
-12,276
-3,263
1,102